Osmont MN - Search Results

1

Hospital databases for the identification of adverse drug reactions: A 2-year multicentre study in 9 French general hospitals.

Osmont MN, Degremont A, Jantzem H, Audouard-Marzin Y, Lalanne S, Carlhant-Kowalski D, Bellissant E, Oger E, Polard E. Osmont MN, et al. Br J Clin Pharmacol. 2021 Feb;87(2):471-482. doi: 10.1111/bcp.14405. Epub 2020 Jun 18. Br J Clin Pharmacol. 2021. PMID: 32484575 Free article.

2

[Use of the PMSI for the detection of adverse drug reactions].

Osmont MN, Cuggia M, Polard E, Riou C, Balusson F, Oger E. Osmont MN, et al. Therapie. 2013 Jul-Aug;68(4):285-95. doi: 10.2515/therapie/2013042. Epub 2013 Aug 28. Therapie. 2013. PMID: 23981266 French.

3

[Peranesthesic Anaphylactic Shocks: Contribution of a Clinical Data Warehouse].

Osmont MN, Campillo-Gimenez B, Metayer L, Jantzem H, Rochefort-Morel C, Cuggia M, Polard E. Osmont MN, et al. Therapie. 2015 Oct 16. doi: 10.2515/therapie/2015055. Online ahead of print. Therapie. 2015. PMID: 26475750 French.

4

Drug safety and big clinical data: Detection of drug-induced anaphylactic shock events.

Bouzillé G, Osmont MN, Triquet L, Grabar N, Rochefort-Morel C, Chazard E, Polard E, Cuggia M. Bouzillé G, et al. Among authors: osmont mn. J Eval Clin Pract. 2018 Jun;24(3):536-544. doi: 10.1111/jep.12908. Epub 2018 Mar 13. J Eval Clin Pract. 2018. PMID: 29532572

5

[Pitch perception modification due to antiepileptics: A literature and pharmacovigilance databases review].

Le Daré B, Triquet L, Degremont A, Charbonnel H, Default A, Osmont MN, Picard S, Gentilhomme G, Bellissant E, Scailteux LM, Polard E. Le Daré B, et al. Among authors: osmont mn. Therapie. 2020 Nov-Dec;75(6):599-604. doi: 10.1016/j.therap.2020.02.017. Epub 2020 Feb 22. Therapie. 2020. PMID: 32204934 Free article. French.

6

The Trigger Tool Method for Routine Pharmacovigilance: A Retrospective Cohort Study of the Medical Records of Hospitalized Geriatric Patients.

Marseau F, Prud'Homm J, Bouzillé G, Polard E, Oger E, Somme D, Osmont MN, Scailteux LM. Marseau F, et al. Among authors: osmont mn. J Patient Saf. 2022 Mar 1;18(2):e393-e400. doi: 10.1097/PTS.0000000000000820. J Patient Saf. 2022. PMID: 33949842

7

Real-world safety profiles of pirfenidone and nintedanib in idiopathic pulmonary fibrosis patients.

Fournier D, Jouneau S, Bouzillé G, Polard E, Osmont MN, Scailteux LM. Fournier D, et al. Among authors: osmont mn. Pulm Pharmacol Ther. 2022 Oct;76:102149. doi: 10.1016/j.pupt.2022.102149. Epub 2022 Jul 30. Pulm Pharmacol Ther. 2022. PMID: 35918026

8

Reality of drug-induced erythema multiforme: A French pharmacovigilance study.

Demouche S, Bettuzzi T, Sbidian E, Laugier Castellan D, Osmont MN, Ingen-Housz-Oro S, Lebrun-Vignes B. Demouche S, et al. Among authors: osmont mn. Therapie. 2023 Nov-Dec;78(6):711-719. doi: 10.1016/j.therap.2023.03.004. Epub 2023 Mar 10. Therapie. 2023. PMID: 37024401

9

Photodermatitis from topical phenothiazines: A case series.

Cariou C, Droitcourt C, Osmont MN, Marguery MC, Dutartre H, Delaunay J, Avenel-Audran M, Dupuy A, Adamski H. Cariou C, et al. Among authors: osmont mn. Contact Dermatitis. 2020 Jul;83(1):19-24. doi: 10.1111/cod.13509. Epub 2020 Mar 25. Contact Dermatitis. 2020. PMID: 32124458 Free article.

10

Reversible anti-TNFα treatment induced dementia: A case report.

Hou C, Azzi E, Salmon A, Osmont MN, Perdriger A. Hou C, et al. Among authors: osmont mn. Joint Bone Spine. 2021 Jan;88(1):105044. doi: 10.1016/j.jbspin.2020.06.017. Epub 2020 Jul 1. Joint Bone Spine. 2021. PMID: 32622041

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

11 results

Search Page